The Biostatistics Core provides statistical collaboration and data management support for each of theSPORE projects, the developmental projects, and the Cores. Each of the projects presented in thisapplication reflects input from members of the Biostatistics Core on study design and analysis plan. TheBiostatistics Core will provide statistical support across many different fields, including statistical genetics,epidemiological studies, basic sciences including gene array, and clinical trials. This comprehensive natureof the Biostatistics Core assures each SPORE investigator access to statistical expertise that includescollaborative development of study designs and analysis plans, state of the an' data analysis andinterpretation, data management resources, and abstract and manuscript preparation. The Biostatistics Corealso provides a mechanism for the management and integration, of both existing and newly collected datathrough consistent and compatible data handling. Areas of support include database development, data formdevelopment and processing, quality control, data collection and entry, and data archiving. This Corecomplements and assists the efforts of other Cores such as the Clinical and Biospecimen Cores by providingdata management expertise and experience with tissue registries such as the Radical Prostatectomydatabase. The Biostatistics Core builds upon the innovative and time-tested procedures and systemsdeveloped by one of the largest statistical groups in the country whose members have collaborated on morethan 10,000 clinical and basic science research studies since 1966.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA091956-08
Application #
7729574
Study Section
Special Emphasis Panel (ZCA1-GRB-I (M1))
Project Start
2008-09-11
Project End
2011-08-31
Budget Start
2008-09-11
Budget End
2009-08-31
Support Year
8
Fiscal Year
2008
Total Cost
$97,605
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Guerrico, Anatilde Gonzalez; Hillman, David; Karnes, Jeffery et al. (2017) Roles of kallikrein-2 biomarkers (free-hK2 and pro-hK2) for predicting prostate cancer progression-free survival. J Circ Biomark 6:1849454417720151
Hearn, Jason W D; AbuAli, Ghada; Reichard, Chad A et al. (2016) HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort study. Lancet Oncol 17:1435-1444
Spratt, Daniel E; Evans, Michael J; Davis, Brian J et al. (2015) Androgen Receptor Upregulation Mediates Radioresistance after Ionizing Radiation. Cancer Res 75:4688-96
Lu, Ji; Lonergan, Peter E; Nacusi, Lucas P et al. (2015) The cistrome and gene signature of androgen receptor splice variants in castration resistant prostate cancer cells. J Urol 193:690-8
Urban, Matthew W; Wang, Chenyi; Alizad, Azra et al. (2015) Complex background suppression for vibro-acoustography images. Ultrasonics 56:456-72
Cooperberg, Matthew R; Davicioni, Elai; Crisan, Anamaria et al. (2015) Combined value of validated clinical and genomic risk stratification tools for predicting prostate cancer mortality in a high-risk prostatectomy cohort. Eur Urol 67:326-33
Alshalalfa, Mohammed; Crisan, Anamaria; Vergara, Ismael A et al. (2015) Clinical and genomic analysis of metastatic prostate cancer progression with a background of postoperative biochemical recurrence. BJU Int 116:556-67
Loeb, Stacy; Sanda, Martin G; Broyles, Dennis L et al. (2015) The prostate health index selectively identifies clinically significant prostate cancer. J Urol 193:1163-9
Ahmed, Kamran A; Davis, Brian J; Mynderse, Lance A et al. (2014) Comparison of biochemical failure rates between permanent prostate brachytherapy and radical retropubic prostatectomy as a function of posttherapy PSA nadir plus 'X'. Radiat Oncol 9:171
Wu, Qiang; Kohli, Manish; Bergen 3rd, H Robert et al. (2014) Preclinical evaluation of the supercritical extract of azadirachta indica (neem) leaves in vitro and in vivo on inhibition of prostate cancer tumor growth. Mol Cancer Ther 13:1067-77

Showing the most recent 10 out of 206 publications